Ticker
CLSDCompany Name
CLEARSIDE BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 15.33M | $ -27.71M | -180.75% |
3/31/2025 | $ 19.67M | $ -30.81M | -156.66% |
12/31/2024 | $ 25.13M | $ -34.35M | -136.72% |
9/30/2024 | $ 29.16M | $ -31.88M | -109.31% |
6/30/2024 | $ 33.93M | $ -33.46M | -98.59% |
3/31/2024 | $ 40.14M | $ -34.97M | -87.11% |
12/31/2023 | $ 34.02M | $ -32.48M | -95.49% |
9/30/2023 | $ 34.42M | $ -37.32M | -108.41% |
6/30/2023 | $ 39.19M | $ -35.88M | -91.56% |
3/31/2023 | $ 44.7M | $ -34.58M | -77.38% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for CLEARSIDE BIOMEDICAL INC is calculated as follows: Net Inc. Cmn. [ $ -14.19M ] / Assets [ $ 17.41M ]
(=) ROA [ -81.55% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.44K |
---|---|
min | -33.4% |
max | 33.98% |
average | 0.12% |
median | 1.53% |
std | 10.61% |